Search Results - "Hegazy, Sahar K."
-
1
Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients
Published in Open medicine (Warsaw, Poland) (09-08-2023)“…Coronavirus disease 2019 (COVID-19) caused a progress in research to find a solution to this pandemic. Also, various advances in pharmacotherapy against…”
Get full text
Journal Article -
2
Clinical study to compare the efficacy and safety of casirivimab & imdevimab, remdesivir, and favipravir in hospitalized COVID-19 patients
Published in Journal of clinical virology plus (01-06-2023)“…•Corona Virus induced disease – 2019 (COVID-19) disaster motivates scientific research to find a settling to this pandemic.•Various advances in immunotherapy…”
Get full text
Journal Article -
3
Pentoxifylline, a nonselective phosphodiesterase inhibitor, in adjunctive therapy in patients with irritable bowel syndrome treated with mebeverine
Published in Biomedicine & pharmacotherapy (01-01-2022)“…Irritable bowel syndrome (IBS) is a functional gastrointestinal condition marked by chronic bowel pain or discomfort, as well as changes in abdominal motility…”
Get full text
Journal Article -
4
Retraction of “Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients”
Published in Open medicine (Warsaw, Poland) (10-11-2023)“…[This retracts the article DOI: 10.1515/med-2023-0768.]…”
Get full text
Journal Article -
5
Antifibrotic effect of aloe vera in viral infection-induced hepatic periportal fibrosis
Published in World journal of gastroenterology : WJG (07-05-2012)“…AIM:To investigate the anti-oxidative and anti-fibrotic effects of aloe vera in patients with liver fibrosis.METHODS:Aloe vera high molecular weight…”
Get full text
Journal Article -
6
Effect of probiotics on pro-inflammatory cytokines and NF-κB activation in ulcerative colitis
Published in World journal of gastroenterology : WJG (07-09-2010)“…AIM: To demonstrate the therapeutic effect of probiotics in patients with ulcerative colitis (UC), and their effect on inflammatory mediators and nuclear…”
Get full text
Journal Article -
7
Mebendazole; from an anti-parasitic drug to a promising candidate for drug repurposing in colorectal cancer
Published in Life sciences (1973) (15-06-2022)“…Metastatic colorectal cancer (mCRC) predominantly contributes to cancer-related mortalities secondary to distant metastasis. This study aimed at investigating…”
Get full text
Journal Article -
8
Repurposing metformin as adjuvant therapy in patients with ulcerative colitis treated with mesalamine: A randomized controlled double-blinded study
Published in International immunopharmacology (10-09-2024)“…UC is triggered by various stimuli such as oxidative stress, antigens, immunity, and environmental factors. These stimuli release inflammatory cytokines such…”
Get full text
Journal Article -
9
Repurposing celecoxib as adjuvant therapy in patients with Parkinsonian disease: a new therapeutic dawn: randomized controlled pilot study
Published in Inflammopharmacology (01-12-2024)“…Background The clinical presentations of Parkinson’s disease (PD), a chronic neurodegenerative condition, include bradykinesia, hypokinesia, stiffness, resting…”
Get full text
Journal Article -
10
Nigella sativa as a promising intervention for metabolic and inflammatory disorders in obese prediabetic subjects: A comparative study of Nigella sativa versus both lifestyle modification and metformin
Published in Journal of diabetes and its complications (01-07-2021)“…This study aimed at evaluating the effect of Nigella sativa (NS) on anthropometric, metabolic and inflammatory parameters and examining its related molecular…”
Get full text
Journal Article -
11
Pentoxifylline in patients with ulcerative colitis treated with mesalamine by modulation of IL-6/STAT3, ZO-1, and S1P pathways: a randomized controlled double-blinded study
Published in Inflammopharmacology (01-10-2024)“…Background Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) that lasts a long time and has a variety of causes. Aim The primary aim of this study…”
Get full text
Journal Article -
12
Comparative randomized trial evaluating the effect of proton pump inhibitor versus histamine 2 receptor antagonist as an adjuvant therapy in diffuse large B-cell lymphoma
Published in Medical oncology (Northwood, London, England) (01-01-2021)“…The development of drug resistance remains the major obstacle to clinical efficacy of cancer chemotherapy. Consequently, finding new therapeutic options for…”
Get full text
Journal Article -
13
Effect of genetic polymorphisms on the development of secondary failure to sulfonylurea in Egyptian patients with type 2 diabetes
Published in Therapeutic advances in endocrinology and metabolism (01-08-2011)“…Objective: This study investigated the possibility that genetic factors, such as polymorphism of K inward rectifier subunit (Kir6.2), E23K, and Arg972…”
Get full text
Journal Article -
14
Open‐label pilot study of ethosuximide as adjunctive therapy for relieving abdominal pain related to Irritable Bowel Syndrome
Published in Journal of clinical pharmacy and therapeutics (01-03-2022)“…What is known and objectives There is clear evidence for an association between irritable bowel syndrome (IBS) and visceral hypersensitivity. This clinical…”
Get full text
Journal Article -
15
A Potential Role of Ethosuximide and Pentoxifylline in Relieving Abdominal Pain in Irritable Bowel Syndrome Patients Treated with Mebeverine: A Randomized, Double-Blind, Placebo-Controlled Trial
Published in Journal of inflammation research (01-01-2022)“…Irritable bowel syndrome (IBS) is defined as an association of chronic abdominal pain with bowel habit abnormalities, without clear organic dysfunction. T-type…”
Get full text
Journal Article -
16
Effect of clarithromycin and fluconazole on the pharmacokinetics of montelukast in human volunteers
Published in European journal of clinical pharmacology (01-09-2012)“…Objective Montelukast, a leukotriene receptor antagonist, is used in the treatment of asthma. The objective of the study reported here was to determine whether…”
Get full text
Journal Article -
17
Alpha-lipoic acid improves subclinical left ventricular dysfunction in asymptomatic patients with type 1 diabetes
Published in The review of diabetic studies (2013)“…Oxidative stress plays an important role in the development of diabetic cardiomyopathy. Alpha-lipoic acid (ALA) is a powerful antioxidant that may have a…”
Get full text
Journal Article -
18
Evaluation of the anti-osteoporotic effects of metformin and sitagliptin in postmenopausal diabetic women
Published in Journal of bone and mineral metabolism (01-03-2015)“…Osteoporosis is the most important metabolic bone disease in patients with diabetes mellitus. Several studies have documented that metformin is osteogenic in…”
Get full text
Journal Article -
19
EFFECT OF FENOFIBRATE ADJUVANT THERAPY ON ENDOTHELIAL DYSFUNCTION AND CARDIOVASCULAR RISK IN EGYPTIAN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Published in Asian journal of pharmaceutical and clinical research (08-02-2020)“…Objective: Endothelial dysfunction is afflicted to the maturation of arteriosclerosis and type 2 diabetes mellitus (T2DM) vascular complications. This study…”
Get full text
Journal Article -
20
A Potential Role of Ethosuximide and Pentoxifylline in Relieving Abdominal Pain in Irritable Bowel Syndrome Patients Treated with Mebeverine: A Randomized, Double-Blind, Placebo-Controlled Trial
Published in Journal of inflammation research (28-02-2022)“…Background and Purpose: Irritable bowel syndrome (IBS) is defined as an association of chronic abdominal pain with bowel habit abnormalities, without clear…”
Get full text
Journal Article